1. Alpha-defensins (α-Defs) in Crohn's disease: decrease of ileal α-Def 5 via permanent methylation and increase in plasma α-Def 1-3 concentrations offering biomarker utility. (10th January 2018) Authors: Cerrillo, E; Moret, I; Iborra, M; Ramos, D; Busó, E; Tortosa, L; Sáez-González, E; Nos, P; Beltrán, B Journal: Clinical and experimental immunology Issue: Volume 192:Number 1(2018:Apr.) Page Start: 120 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P051 DNA methylation signatures associated with pathogenesis Crohn's disease-related genes. (25th January 2019) Authors: Moret Tatay, I; Cerrillo, E; Sáez-González, E; Hervás, D; Iborra, M; Sandoval, J; Busó, E; Tortosa, L; Nos, P; Beltrán, B Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S111 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P309 Faecal calprotectin and plasma cytokines in the prediction of early postoperative Crohn's disease recurrence. (16th January 2018) Authors: Cerrillo, E; Moret, I; Iborra, M; Hervás, D; Tortosa, L; Sáez-González, E; Nos, P; Beltrán, B Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S257 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P364 Stopping azathioprine in monotherapy after very prolonged remission in inflammatory bowel disease patients: Novel relapse risk factors. (16th January 2018) Authors: Iborra, M; Herreras, J; Boscá-Watts, M; Cortés, X; Trejo, G; Beltran, B; Cerrillo, E; Minguez, M; Nos, P Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S288 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P383 Ustekinumab as an opportunity for refractory Ulcerative Colitis patients. (21st January 2022) Authors: Iborra, M; Soutullo, C; Gimeno, M; Bastida, G; Aguas, M; Cerrillo, E; Sáez-González, E; Garrido, A; Mínguez, A; Bordetas, J; Nos, P Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i383 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P576 Ustekinumab levels correlate with induction fecal calprotectin drop-slope and discriminate the need for intensification at week 52 in Crohn's Disease patients. (27th May 2021) Authors: Mateos, B; Sáez-González, E; Iborra, M; Moret, I; Cañada, A; Tortosa, L; Bastida, G; Aguas, M; Cerrillo, E; Nos, P; Beltrán, B Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S533 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P652 Therapeutic drug monitoring during induction therapy with Ustekinumab in patients with Crohn's disease: the key to early identification of patients with inadequate response. (30th January 2023) Authors: Mínguez, A; Bastida, G; Terol, I; Argumánez, V; Iborra, M; Aguas, M; Moret, I; Cerrillo, E; Garrido, A; Tortosa, L; Nos, P Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i781 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗